NASH HOSPITALS INC — History
CCN 340147 | 3-year financial timeline | COVID resilience: 63/100
🛡️ Public data only — no PHI permitted on this instance.
$321M
Latest Revenue (FY2022)
-0.4%
Revenue CAGR (3yr)
12.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $323M | $326M | $321M | -1.8% | -0.4% |
| Operating Expenses | $309M | $310M | $280M | -9.8% | -4.9% |
| Operating Margin | 4.2% | 5.0% | 12.8% | +153.8% | +73.9% |
| Net Income | $14M | $16M | $41M | +149.2% | +73.3% |
| Licensed Beds | 322 | 322 | 322 | +0.0% | +0.0% |
| Total Patient Days | 54,698 | 55,753 | 59,772 | +7.2% | +4.5% |
| Medicare Day % | 33% | 28% | 25% | -10.4% | -13.5% |
| Medicaid Day % | 18% | 5% | 5% | -2.4% | -46.9% |
COVID Impact & Recovery
Resilience Score: 63/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: -0.7% ($323M → $321M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-0.4%
This Hospital
+7.6%
State Avg
Latest Margin
12.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $319M | 17.0% |
| FY2024 (proj) | $318M | 21.3% |
| FY2025 (proj) | $317M | 25.6% |